Therapix Biosciences (TRPXD) Short Interest Ratio & Short Volume

Short interest is the volume of Therapix Biosciences shares that have been sold short but have not yet been closed out or covered. As of October 30th, traders have sold 1,600 shares of TRPXD short. Learn More on Therapix Biosciences' current short interest.

Therapix Biosciences saw a decrease in short interest in the month of October. As of October 30th, there was short interest totaling 1,600 shares, a decrease of 93.8% from the previous total of 25,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Therapix Biosciences: GelStat Corp. (0.00%), NovAccess Global Inc. (0.19%), Aptevo Therapeutics Inc. (5.13%), Acura Pharmaceuticals, Inc. (0.01%), Predictive Technology Group, Inc. (0.00%), Adhera Therapeutics, Inc. (0.00%), Propanc Biopharma, Inc. (0.01%), RegeneRx Biopharmaceuticals, Inc. (0.01%), China SXT Pharmaceuticals, Inc. (4.78%), Allarity Therapeutics, Inc. (9.18%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.15 billion), Aon plc ($3.50 billion), Snap Inc. ($3.18 billion), Analog Devices, Inc. ($2.90 billion), The Clorox Company ($2.87 billion), Uber Technologies, Inc. ($2.01 billion), The Kroger Co. ($1.86 billion), International Flavors & Fragrances Inc. ($1.80 billion), Moderna, Inc. ($1.80 billion), and Simon Property Group, Inc. ($1.72 billion). View all of the most shorted stocks.

Short selling TRPXD is an investing strategy that aims to generate trading profit from Therapix Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Therapix Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TRPXD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRPXD, twice per month. The most recent reporting period available is October, 30 2020.